Abstract
The effects of single oral doses of DN-2327 (DN, 2 mg or 3 mg), a newly developed partial benzodiazepine receptor agonist, and alprazolam (APZ, 0.8 mg), a full receptor agonist, on psychomotor function and short-term memory were assessed using three psychometric tests: letter cancellation, visual vigilance and Sternberg's memory scanning task. Twelve healthy male volunteers participated in this study. Randomized, double-blind, cross-over test sessions were conducted at 2-week intervals. Both 3 mg DN and 0.8 mg APZ increased the time to completion of the letter cancellation task at 3 h after administration, but neither had any effect on accuracy of response. In the visual vigilance task, which required relatively intense concentration and continuous attention, both the number of errors and reaction times to correct responses significantly increased from 1.5 to 3.5 h after administration of 3 mg DN and at 3.5 h after administration with 0.8 mg APZ. DN at 2 mg also significantly increased the number of errors from 1.5 to 3.5 h after administration, but it did not affect reaction times. In the memory scanning task, 3 mg DN, but not 2 mg DN or APZ, significantly increased overall reaction times at 2 h after administration. These performance deficits paralleled the time-course changes in serum concentrations of both drugs and appeared to be associated with the hypnotic-sedative effects of the drugs tested. These findings did not support those of previous preclinical studies of DN, indicating superiority of DN over conventional full benzodiazepine agonists/anxiolytics in terms of adverse behavioral consequences.
Similar content being viewed by others
References
Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S (1986) Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9:519–524
Curran HV (1986) Tranquillizing memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 23:179–213
Diller L, Ben-Yishay Y, Gerstman LJ, Goodkin R, Gordon W, Weinberg J (1974) Studies in cognition and rehabilitation in hemiplegia (Rehabilitation Monograph No. 50). New York University Medical Center Institute of Rehabilitation Medicine, New York
Erwin CW, Wiener EL, Linnoila MI, Truscott TR (1978) Alcohol-induced drowsiness and vigilance performance. J Stud Alcohol 39:505–516
Ishigooka J (1992) Amnesia induced by hypnotics. Nichigoku Iho 37:10–21 (in Japanese with English abstract)
Johnson LC, Chenik DA (1982) Sedative-hypnotics and human performance. Psychopharmacology 76:101–113
Kato S, Wakasa Y, Nakanishi H, Sei M, Yanagida T (1992) Assessment of dependence potential of DN-2327 in rhesus monkeys. Preclin Rep Cent Inst Exp Anim 18:1–12 (in Japanese with English abstract)
Lader M (1983) Dependence on benzodiazepines. J Clin Psychiatry 44:121–127
Linnoila M, Mattila MJ (1973) Drug interaction on psyhomotor skills related to driving: diazepam and alcohol. Eur J Clin Pharmacol 5:186–194
Sternberg S (1966) High-speed scanning in human memory. Science 153:652–654
Sternberg S (1969) The discovery of processing stages: extensions of Donder's method. In: Koster WG (ed) Attention and performance II. Acta Psychol 30:276–315
Subhan Z (1984) The effects of benzodiazepines on short-term memory and information processing. Psychopharmacology Suppl. 1:173–181
Subhan Z, Hindmarch I (1984) Effects of zopiclone and benzodiazepine hypnotics on search in short-term memory. Neuropsychobiology 12:244–248
Suzuki M, Uchiumi M, Murasaki M (1993a) Effects of buspirone and bromazepam on attention and short-term memory in Japanese healthy volunteers. Jpn J Neuropsychopharmacol 15:453–463 (in Japanese with English abstract)
Suzuki M, Uchiumi M, Murasaki M (1993b) Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on daytime sleepiness and psychomotor functions: a comparative double-blind study with diazepam. Jpn J Psychopharmacol 13:213–224
Takeda Pharmaceuticals Co., Ltd (1992) DN-2327: phase I trial and pilot study for early Phase II trial. Confidential paper (in Japanese)
Uchiumi M, Suzuki M, Ishigooka J, Murasaki M, Miura S (1992) Effects of DN2327, new anxiolytic, upon daytime sleepiness. Abstract for the 18th Congress of Collegium Internationale Neuro-Psychopharmacologium, Clin Neuropharmacol 15 [Suppl. 1, Part B]:541B
Wada T, Fukuda N (1991a) Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology 104:444–450
Wada T, Fukuda N (1991b) Pharmacologic profile of a new anxiolytic, DN-2327:effect of Ro15-1788 and interaction with diazepam in rodents. Psychopharmacology 103:314–322
Wada T, Fukuda N (1992) Effect of a new anxiolytic, DN-2327, on learning and memory. Pharmacol Biochem Behav 41:573–579
Wada T, Nakajima R, Kurihara E, Narumi S, Masuoka Y, Goto G, Saji Y, Fukuda N (1989) Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327. Jpn J Pharmacol 49:337–349
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Suzuki, M., Uchiumi, M. & Murasaki, M. A comparative study of the psychological effects of DN-2327, a partial benzodiazepine agonist, and alprazolam. Psychopharmacology 121, 442–450 (1995). https://doi.org/10.1007/BF02246492
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246492